Supported by over two decades of international experience in regulatory approval, health-technology-assessment, clinical data generation & commercial sales, Stratarium Sàrl collaborates with innovative technology medtechs to establish awareness and credibility in selected markets, including the complex single-payer UK market
Stratarium seeks to work with recently commercialised or pre-commercial technologies that require a made-to-measure clinical evaluation & market development strategy aligned with the manufacturer’s resources
Stratarium’s unique offering is to then invest its own resources and share risk with manufacturers, in exchange for an appropriate return based on agreed objectives
